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ABSTRACT 
Objective: Epilepsy is a chronic neurological disorder affecting 1 % of the population worldwide. A number of studies have reported 
neuroprotective, anticonvulsant and anti-oxidant activity of gossipin a bioflavonoid isolated from Hibiscus vitifolius. The present study was carried 
out to evaluate the acute effects of liposome entrapped gossypin on Increasing Current electroshock seizures (ICES) test; Pentylenetetrazole (PTZ) 
induced seizures and status epilepticus in mice. 
Methods: Gossypin liposomes were prepared by film hydration technique, and the effect of liposomal Gossypin formulations was studied in two 
doses i.e. 2.5 mg/kg and 5 mg/kg given per oral on ICES test and PTZ induced seizures in mice. Same doses of the formulation were administered by 
intravenous route during PTZ induces status epilepticus in mice.  
Results: The results indicated that liposome entrapped Gossypin in doses 2.5 mg/Kg and 5 mg/Kg demonstrated significant increase in seizure threshold 
and latency to generalized seizures in ICES test and PTZ induced seizures respectively. Oxidative stress parameters like malondialdehyde (MDA) and 
glutathione were estimated in brain tissues in mice. Increased levels of MDA and glutathione were reduced and liposomal Gossypin suppressed the 
progression of kindling in mice. These results suggest that liposomal Gossypin appears to possess protective activity against kindling in mice. 
Conclusion: To conclude, the study supports that liposomal Gossypin offers protection against PTZ kindling in mice. Liposomal Gossypin 
administration significantly reduced the progression of kindling in mice therefore it could be a promising candidate to control both development of 
seizures and oxidative stress during epilepsy. 
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INTRODUCTION 
Epilepsy is a neurological disorder that affects a wide range of 
people throughout the world. It is a disorder of the brain 
characterized by the unpredictable and periodic occurrence of a 
transient alteration of behavior due to the disordered, synchronous 
and rhythmic firing of populations of brain neurons [1]. 
In the early 1990s, many new antiepileptic drugs (AEDs) have entered 
the market. Despite, the therapeutic arsenal of old and new AEDs, 
approximately 30 % of patients with epilepsy still suffer from seizures.  
As the majority of antiepileptic drugs are consumed life long, 
concomitant administration of other drugs predisposes to the risk of 
drug interaction [1].  
Adverse effects of AEDs are common and can have a considerable 
impact on quality of life and contribute to treatment failure in up to 
40 % of patients. The most common adverse effects are dose 
dependent and reversible. Idiosyncratic effects, such as skin rashes, 
and chronic effects, such as weight gain, can lead to high rates of 
treatment discontinuation and complicate clinical management. 
Nearly all conventional AEDs increase the risk of congenital 
malformations when taken during pregnancy, with valproate posing 
a potentially greater risk.  
Data from clinical and experimental reports suggest the involvement 
of oxidative stress in the pathophysiology of epilepsy [2]. 
Excessive oxidative stress contributes to neuronal degeneration 
through lipid peroxidation and decreased glutathione 
concentrations in the epileptic focus [3]. 
Thus, it is necessary to investigate for an antiepileptic agent that is 
highly efficacious as well as safe in terms of drug related toxicity. 
Ongoing research on certain plant products has paved the way 
towards the development of the newer category of AEDs therapy [4]. 
Flavonoids are polyphenolic compounds that occur ubiquitously in 
foods of plant origin. Over 4000 different naturally occurring 
flavonoids have been described. The flavonoids show various 
biological activities including antioxidant, anti-inflammatory 
activity, cardioprotective and antitumor activity [5]. 
Gossypin a bioflavonoid (gossypin-8-0 glucoside; 3, 5, 7, 3, 4-
pentahydroxy-8-0-glucosylflavone), is naturally occurring in various 
plants belonging to the family of Malvaceae [6]. 
Gossypin has been found to possess anti-carcinogenic, anti-allergic, anti-
diabetic, anti-inflammatory and neuroprotective effects [5, 7-10] 
Gossypin (10 and 20 mg/kg, per oral p. o) was reported to have 
anticonvulsant activity against pentyelene tetrazole, strychnine and 
maximal electroshock-induced seizures in mice [11]. Data from the 
study suggested that gossypin showed neuroprotection/seizure 
protection probably through GABA (gamma amino butyric acid) 
aminergic and glycine inhibitory mechanism. Although Gossypin 
possesses anticonvulsant activity but the same as a formulation is 
still not available. Thus, in view of the above liposomal formulations 
of gossypin were formulated and tested against ICES test, PTZ 
induced seizures and status epilepticus in mice. 
Further MDH and glutathione levels were also measured to 
determine if oxidative stress was involved in epilepsy. 
MATERIALS AND METHODS 
Animals 
Healthy Swiss albino inbred mice weighing 24-30 g was used. The 
animals were acquired from the animal house facility from the 
central animal house Amity University. 
Animals were housed in a group of six mice per cage with free access 
to pellet diet and water. Care of animals was taken as per the 
guidelines of committee for the purpose of central and supervision 
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of experiments on animals, and the study was approved by 
Institutional Animal Ethics Committee, Amity Institute of Pharmacy, 
Amity University (CPCSEA/AIP/2013/12/04). 
Drugs and dosing schedule 
Gossypin, PTZ, Cholesterol, Dipalmitoyl phosphatidylcholine, 
Distearoyl phosphatidylcholine & Egg phosphatidylcholine were 
purchased from M/S Sigma-Aldrich USA. 
In order to perform experiments, liposomal Gossypin was prepared 
by Film hydration technique. Briefly, the desired amounts of lipid 
and cholesterol were weighed (including drug) into 50 ml pear-
shaped flask, and 4 mL of chloroform and methanol mixture (1:1) 
was added to dissolve lipids. The organic solvent mixture was then 
removed under vacuum using rotary evaporator at 60 °C for 30 min, 
after which the flask was kept under vacuum overnight to remove 
completely any residual solvent.  
Encapsulation of Gossypin into liposomes was accomplished by the 
addition of pH 7.4 phosphate buffer saline (PBS) containing 2 % 
Poloxamer P188. Dry lipids were hydrated with PBS [12]. 
The prepared liposomes were characterized for particle size 
(measured by photon correlation spectroscopy), particle shape 
through optical microscopy and TEM [12, 13]. 
Gosssypin containing liposomes were prepared using different 
phospholipids viz. dipalmitoyl phosphatidylcholine (PPCL), 
distearoyl phosphatidylcholine (SPCL), Egg phosphatidylcholine 
(EPCL), 1-2-dimyristoyl-sn-glycero-3-phosphocholine (MPCL) and 
were evaluated for entrapment efficiency and in-vitro drug release. 
Formulation EPCL (table 1) containing egg phosphatidylcholine 
showed highest entrapment efficiency of 89.29 % and an in-vitro 
drug release of 83.441 %. EPCL was selected as the final optimized 
formulation. 
The effect of liposomal gossypin formulation was studied in two 
doses 2.5 mg/Kg & 5 mg/Kg given per oral on ICES test and PTZ 
induced seizures in mice. 
Same doses of the formulation were administered by intravenous 
route during PTZ induced status epilepticus in mice. For ICES and PTZ 
induced seizure test control animals received (placebo) formulation 
orally.  
However, in status epilepticus model the animals received the 
liposome (placebo) formulation intravenously (i/v).  
Placebo formulations (without drug) were given in order to assess 
that the anti-epileptic effect was only due to Gossypin and not of any 
other excipient present in the formulation. 
Evaluation of liposomal formulations in animal models 
ICES test 
The ICES test as proposed by Kitano [14] and modified by Marwah 
[15] was used to evaluate the anti convulsogenic effect of 
formulations. 
Starting with a current of 2 milliamperes (mA) electroshock was 
delivered to each mouse via ear electrode as a single train of pulses 
(for 0.2 s). 
The current at which tonic hind limb extension was observed was 
recorded as seizure threshold current. If no tonic hind limb 
extension was observed by a current of 30 mA, electroshock was 
terminated. 
PTZ induced seizure model 
PTZ [16] seizures were induced with a dose of 60 mg/kg, 
intraperitoneally (i. p) this being the dose that produced myoclonic 
jerks and generalized seizures in all animals without mortality. The 
formulation was administered to the animals 30 min prior to the 
administration of PTZ. The animals were observed for 30 min by 
placing them in a separate cage. The latency to generalized seizures 
was recorded. In the absence of seizures within 30 min, the latency 
time was taken as 1800 s. 
Status epilepticus 
The method as proposed by Raines [17] was used to induce status 
epilepticus. Phenytoin sodium (40 mg/Kg) dissolved in alkaline 
saline was administered i. p. in a volume of 0.1 ml/10 g body weight, 
to prevent the terminal tonic hind limb extension produced by PTZ 
which was administered 2 h later, in a dose of 80 mg/Kg through 
subcutaneous(s/c) route. The time needed for the development of 
unequivocal sustained clonic seizure activity involving the limbs was 
noted. Seizure Free State of 1 h was taken as protection. The 
formulation was administered i/v and the observation was made 30 
min after administration. 
Measurement of oxidative stress parameters 
Tissue preparation 
At the end of the study period, the animals were sacrificed under 
deep anesthesia; the brain was quickly dissected out, washed with 
ice-cold sodium phosphate buffer, weighed and stored over ice. The 
brains wee further processed within half an hour of dissection, and 
the oxidative stress parameters were conducted on the same 
working day. Brain tissues were homogenized in a volume 10 times 
weight/Volume (w/v) sodium phosphate buffer (7.4 pH, ice cold, a 
mixture of potassium dihydrogen phosphate and disodium hydrogen 
phosphate). The homogenate was centrifuged at 3000 rpm for 15 
min. The supernatant was collected for estimation of various 
oxidative stress parameters. 
Measurement of lipid peroxidation 
MDA, which is a measure of lipid peroxidation, was measured 
spectrophotometrically by the method described by Okhawa [18]. 
Reduced glutathione was estimated spectrophotometrically by the 
method described by Ellman [19]. 
The data were expressed as mean±standard error means (SEM), and 
the results were analyzed by ANOVA followed by Tukey’s test. p-
value less than equal to 0.05 was considered significant. 
RESULTS AND DISCUSSION 
Characterization of liposome’s 
Vesicle size 
The size of the drug loaded liposomes was carried out using Master 




Fig. 1: Vesicle size for optimized formulation 
 
Vesicle shape 
Vesicle Shape of the liposomes was analyzed by optical microscopy. 
Pictures of liposomes (fig. 2) were taken at a magnification of above 
44 times by Nikon camera. 
The liposomes were spherical and bilamellar. The TEM of optimized 
formulation also showed the presence of spherical particles (fig. 3). 
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Fig. 2: Microscopic picture of the optimized formulation 
 
Fig. 3: TEM picture of the optimized formulation
 
Table 1: In-vitro drug release and entrapment efficiency 












EPCL 10 41.80 17.40 0.2 88.81±0.30 83.41±0.52 
MPCL 10 37.38 1740 0.2 43.19±0.54 54.37±0.25 
PPCL 10 40.37 17.40 0.2 98.40±0.39 64.80±0.38 
SPCL 10 43.45 17.40 0.2 82.45±0.26 60.00±0.20 
SLL 10 37.28 17.40 0.2 98.68±0.28 66.96±0.34 
Number of Samples used 03, Data expressed as mean±SD 
 
Animal studies 
The results indicated that liposome entrapped gossypin was able to 
cross the blood-brain barrier as indicated by the mass 
spectrophotometric analysis of brain homogenate solutions (fig. 4) 
of formulation treated mice. Liposome entrapped gossypin 
increased seizure threshold current as compared to vehicle treated 
and placebo treated animals in ICES test. 
  
 
Fig. 4: Mass spectrophotometric analysis of brain homogenate 
 
Table 2: Effect of liposomal formulation (F1 & F2) in ICES test in mice 
Groups Treatment Dose ICES seizure threshold (mA) 
I Vehicle 10 ml/Kg 15.33±1.63 
II Placebo 10 mL/Kg 14.38±0.67 
III F1 2.5 mg/Kg 26.66±3.01 
IV F2 5 mg/Kg 27.16±2.22* 
A number of animals used 6, Data expressed as mean±SEM ANNOVA followed by Tukey’s Test P<0.05 was considered statistically significant, F1 and 
F2 are liposomal gossypin formulations, *p<0.05 Vehicle vs F2, Liposome-entrapped Gossypin also increased the latency to PTZ induced generalized 
seizure as compared to vehicle and placebo.  
Katare et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 4, 247-251 
250 
Table 3: Effect of liposomal formulation (F1 & F2) in PTZ induced seizures 
Groups Treatment Dose Latency to generalized seizures (s) 
I Vehicle 10 ml/Kg 90.66±3.93 
II Placebo 10 mL/Kg 98.16±2.07
III 
c* 
F1 2.5 mg/Kg 135.5±8.47
IV 
a* 
F2 5 mg/Kg 212.6±16.69b* 
A number of animals used 6, Data expressed as mean±SEM ANNOVA followed by Tukey’s Test, P<0.05 was considered statistically significant, F1 
and F2 are liposomal gossypin formulations, *a p<0.05 Vehicle Vs. F2, *b p<0.05 Placebo Vs. F2, *c p<0.05 Vehicle Vs. F1 
Also, in PTZ induced status epilepticus liposome entrapped Gossypin increased latency and duration of generalized clonic seizures  
 
Table 4: Effect of liposomal formulation (F1 & F2) in PTZ induced status epilepticus 
Groups Treatment Dose PTZ induced status Epilepticus 
Latency (min) Duration (min) 
I Vehicle 10 ml/Kg 12.83±1.56 32.18±2.10 
II Placebo 10 mL/Kg 19.73±1.93 35.66±2.10 
III F1 2.5 mg/Kg 25.33±1.93 21.37±2.05a**,b* 
IV 
d*, 
F2 5 mg/Kg 32.63±2.51 15.67±1.06c* e* 
Number of animals used 6, Data expressed as mean±SEM ANNOVA followed by Tukey’s Test, P<0.05 was considered statistically significant, F1 and 
F2 are liposomal gossypin formulations, a** p<0.01 Vehicle Vs. F1, b*p<0.05 Placebo Vs. F1, c*p<0.01 Vehicle Vs. F2, d*p<0.01 Vehicle Vs. F1, e*
 
Free radicals are normal products of aerobic cellular metabolism 
involved in the development of seizures. Repeated PTZ administration 
has significantly increased free radical generation as indicated by 
increased MDA level in the vehicle treated PTZ kindled mice (table 5). 
p<0.01 
vehicle Vs. F2 
In the present study decreased level of glutathione was observed in 
the vehicle-treated PTZ kindled mice. Gossypin liposomal 
formulations demonstrated increased glutathione levels in kindled 
mice brain tissue (table 5). 
 
Table 5: MDA and Glutathione levels in formulation treated groups measured in n moles/g wet tissue and µg/g wet tissue respectively 
S. No. Treatment/Parameters MDA levels Glutathione levels 
1. Control 0.95±0.187 125±17.60 
2. PTZ Treated 1.91±0.160***a 303±16.33***a 
3. PTZ+F1Treated 1.31±0.116***b 203±17.51***b 
4 PTZ+F2Treated 1.36±0.19***b 201±21.36***b 
Data was expressed as mean±SEM, n=6; statistical analysis was done by ANOVA, ***p<0.001, a Vs control, b Vs PTZ. 
 
Among the novel drug delivery system liposomes can be used to 
enhance the bioavailability and target the drugs to the brain [20]
This data suggests that oral administration of liposome-entrapped 
gossypin prevents electron convulsions and PTZ induced seizures. 
Also intravenous administration of liposome-entrapped gossypin 
was helpful in status epilepticus. 
. 
The enhanced effect could be associated to the fact phospholipids 
carriers can easily cross Blood-brain barrier. This data is in 
concurrence with other findings where improved effects have been 
obtained through the use of liposomes as compared to conventional 
drug delivery systems [21, 22]. 
Mechanism of action of gossypin on seizures is not completely 
established. Some of the suggested mechanism probably may be 
affecting both GABA aminergic and glycine inhibitory mechanism. 
However, further biochemical and clinical studies are required for 
developing a promising formulation as an alternative to the existing 
anticonvulsant therapy opted during epilepsy. 
CONCLUSION  
To conclude, the study supports that liposomal Gossypin offers 
protection against PTZ kindling in mice. Liposomal Gossypin 
administration significantly reduced the progression of kindling in 
mice therefore it could be a promising candidate to control both 
developments of seizures and oxidative stress during epilepsy. 
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